Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients.
Toxicol Rep
; 9: 46-52, 2022.
Article
in English
| MEDLINE | ID: covidwho-1586408
ABSTRACT
Communicable diseases (CDs) based on Health organization reported are one of the most threat for human health. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the main pandemic that nowadays it threatens the health of people around the world, especially cancer patients. The purpose of this study was to investigate the effects of COVID-19 acute respiratory disease (COVID-19 ARD) on risk factors related to health of cancer patients. A review study of was conducted to base on results of various studies published. Nine hundred and eighty articles were retrieved based on various databases Science Direct, Taylor & Francis, Google Scholar, Elsevier, PubMed and BMJ. In this study, were used the results of research on COVID-19 and its effects on risk factors attributed to cancer patients. The literature signs a notable undesirable affect from COVID-19 on risk factors attributed to health of cancer patients. Result showed that transfer SARS-CoV-2 viruses can endanger health of cancer patients due to interruption of the disease treatment process and increase number of deaths between in this patents. The survey requires the need to act creating healthy conditions to continue the treatment process and vaccination coverage among these patients in order to decrease the transmission of COVID-19 acute respiratory disease and increase the success rate of cancer treatment.
AACR, American Association of Cancer Research; ASCO, American Society of Clinical Oncology; Acute respiratory disease; CCC-19, COVID-19 and Cancer Consortium; CDs, Communicable diseases; COVID-19; COVID-19 ARD, acute respiratory disease; COVID-19, coronavirus disease 2019; Cancer; Communicable diseases; ESCA, Esophageal carcinoma; ESMO, European Society for Medical Oncology; Health; ICU, Intensive Care Unit; KICH, Kidney Chromophobe; KIRP, Kidney renal papillary cell carcinoma; LUAD, Lung adenocarcinoma; PCR, Real-time Polymerase Chain Reaction; PRAD, Prostate adenocarcinoma; Risk factors; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; UCEC, Uterine Corpus Endometrial Carcinoma; WHO, World Health Organization
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Reviews
Topics:
Vaccines
Language:
English
Journal:
Toxicol Rep
Year:
2022
Document Type:
Article
Affiliation country:
J.TOXREP.2021.12.004
Similar
MEDLINE
...
LILACS
LIS